Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JAGX
JAGX logo

JAGX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jaguar Health Inc (JAGX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.720
1 Day change
-0.37%
52 Week Range
171.500
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

JAGX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading pre-market around 3.06, but the technical setup is still weak, with bearish moving averages and no strong buy signal from Intellectia's proprietary signals. Given the lack of recent news, no clear financial snapshot, neutral hedge fund and insider activity, and no supportive analyst or options evidence, the stock does not offer a strong enough setup for an impatient buyer seeking a clear entry.

Technical Analysis

The current trend is mixed to weak. MACD histogram is positive at 0.383 but is contracting, which suggests momentum is not strengthening. RSI_6 at 37.807 is neutral to slightly weak, not signaling an oversold rebound. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which usually indicates the broader trend remains under pressure. Price is below the pivot at 3.343 and near support at 2.903, so the stock is trading in a technically fragile area. The model trend view suggests small upside over a month, but the near-term outlook is still choppy.

Positive Catalysts

  • Pre-market trading is showing a price around 3.06, which is above the immediate lower support zone and could attract short-term interest. The MACD histogram is still positive, and the model trend estimate suggests possible upside over the next month. Also, there is no recent negative news flow, which removes an immediate sentiment overhang.

Neutral/Negative Catalysts

  • There is no valuation data, no financial snapshot available, no analyst target/rating update provided, and no recent congress trading data. Intellectia signals also show no AI Stock Picker or SwingMax buy signal today.

Financial Performance

No usable latest-quarter financial data was provided because the financial snapshot returned an error. As a result, there is no reliable quarter-season growth review available from the dataset.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a favorable Wall Street upgrade trend or rising target prices. Based on the available data, Wall Street sentiment cannot be considered constructive.

Wall Street analysts forecast JAGX stock price to rise
Analyst Rating
0
Wall Street analysts forecast JAGX stock price to rise
Buy
Hold
Sell
0
Current: 2.820
sliders
Low
0
Averages
0
High
0
0
Current: 2.820
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch